REPURCHASE OF NOTES AT OPTION OF HOLDERS. References to the “Company” in the definition of “Fundamental Change” in Section 1.01 of the Indenture shall instead be references to “Parent”. Except as amended hereby, the purchase rights set forth in Section 4.02 of the First Supplemental Indenture shall continue to apply.
Appears in 2 contracts
Samples: Second Supplemental Indenture (Xeris Pharmaceuticals Inc), Second Supplemental Indenture (Xeris Biopharma Holdings, Inc.)
REPURCHASE OF NOTES AT OPTION OF HOLDERS. References to the “Company” in the definition of “Fundamental Change” in Section 1.01 of the Base Indenture shall instead be references to “Parent”. Except as amended hereby, the purchase rights set forth in Section 4.02 3.02 of the First Supplemental Base Indenture shall continue to apply.
Appears in 2 contracts
Samples: First Supplemental Indenture (Nuvasive Inc), First Supplemental Indenture (Globus Medical Inc)
